An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction

This publication has 15 references indexed in Scilit:

• Medical costs of coronary artery disease in the United States
  The American Journal of Cardiology, 1990
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.
  Circulation, 1987
• Economic evaluation and the rational diffusion and use of health technology
  Health Policy, 1987
• Cholesterol Reduction and Life Expectancy
  Annals of Internal Medicine, 1987
• Cost-Effectiveness of Interventions to Prevent or Treat Coronary Heart Disease
  Annual Review of Public Health, 1985
• The Lipid Research Clinics Coronary Primary Prevention Trial Results
  JAMA, 1984
• The Lipid Research Clinics Coronary Primary Prevention Trial Results
  JAMA, 1984
• Foundations of Cost-Effectiveness Analysis for Health and Medical Practices
  New England Journal of Medicine, 1977
• Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease
  Annals of Internal Medicine, 1971